Page last updated: 2024-09-05

symmetric dimethylarginine and Critical Illness

symmetric dimethylarginine has been researched along with Critical Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fraites, T; Köster, LS; Peda, A; Sithole, F1
Bruensing, J; Buendgens, L; Dückers, H; Koch, A; Kunze, J; Luedde, T; Matthes, M; Tacke, F; Trautwein, C; Weiskirchen, R1

Other Studies

2 other study(ies) available for symmetric dimethylarginine and Critical Illness

ArticleYear
A preliminary investigation into the prognostic relevance of symmetric dimethylarginine in critically ill dogs.
    Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2018, Volume: 28, Issue:6

    Topics: Acute Kidney Injury; Animals; Arginine; Biomarkers; Case-Control Studies; Critical Illness; Dog Diseases; Dogs; Female; Male; Predictive Value of Tests; Prognosis; Prospective Studies

2018
Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.
    Mediators of inflammation, 2013, Volume: 2013

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Critical Care; Critical Illness; Female; Gene Expression Regulation; Humans; Inflammation; Male; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Prognosis; Regression Analysis; Risk Factors; Sepsis; Young Adult

2013